{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:50:54Z","timestamp":1789512654576,"version":"build-2803163510"},"reference-count":302,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.pharmthera.2009.05.006","type":"journal-article","created":{"date-parts":[[2009,5,29]],"date-time":"2009-05-29T16:59:07Z","timestamp":1243616347000},"page":"353-370","source":"Crossref","is-referenced-by-count":254,"title":["30\u00a0years of dynorphins \u2014 New insights on their functions in neuropsychiatric diseases"],"prefix":"10.1016","volume":"123","author":[{"given":"Christoph","family":"Schwarzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2009.05.006_bib1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0028-3908(02)00167-3","article-title":"Postsynaptic effects of GABAergic synaptic diversity: regulation of neuronal excitability by changes in IPSC variance","volume":"43","author":"Aradi","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib2","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1073\/pnas.92.11.5062","article-title":"The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids","volume":"92","author":"Arvidsson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0169-328X(94)90143-0","article-title":"Prodynorphin gene expression relates to NF-kappa B factors","volume":"24","author":"Bakalkin","year":"1994","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(90)90512-A","article-title":"Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis","volume":"507","author":"Bakshi","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/74263","article-title":"Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress","volume":"24","author":"Bale","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-3565(25)10296-6","article-title":"Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats","volume":"264","author":"Bals-Kubik","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/scan\/nsm029","article-title":"Amygdala-frontal connectivity during emotion regulation","volume":"2","author":"Banks","year":"2007","journal-title":"Soc Cogn Affect Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1517\/13543784.6.10.1351","article-title":"Novel developments with selective, non-peptidic kappa-opioid receptor agonists","volume":"6","author":"Barber","year":"1997","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib9","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/j.1471-4159.1993.tb03314.x","article-title":"Kappa-opioid agonist modulation of [3H]thymidine incorporation into DNA: evidence for the involvement of pertussis toxin-sensitive G protein-coupled phosphoinositide turnover","volume":"60","author":"Barg","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ar.a.20184","article-title":"Vesicular glutamate transporter-1 colocalizes with endogenous opioid peptides in axon terminals of the rat locus coeruleus","volume":"284","author":"Barr","year":"2005","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(79)91001-1","article-title":"Efferent connections of the substantia nigra and ventral tegmental area in the rat","volume":"175","author":"Beckstead","year":"1979","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1471-4159.1998.70020635.x","article-title":"Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits","volume":"70","author":"Belcheva","year":"1998","journal-title":"J Neurochem"},{"issue":"Suppl 3","key":"10.1016\/j.pharmthera.2009.05.006_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1528-1157.2001.042suppl.3005.x","article-title":"Cell death and synaptic reorganizations produced by seizures","volume":"42","author":"Ben-Ari","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib14","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1046\/j.1471-4159.2000.0751763.x","article-title":"Defective prodynorphin processing in mice lacking prohormone convertase PC2","volume":"75","author":"Berman","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.psyneuen.2007.12.010","article-title":"Control of hormonal stress reactivity by the endogenous opioid system","volume":"33","author":"Bilkei-Gorzo","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.alcohol.2006.12.002","article-title":"Reduced alcohol consumption in mice lacking preprodynorphin","volume":"40","author":"Blednov","year":"2006","journal-title":"Alcohol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.psychres.2006.11.004","article-title":"The price of seizure control: dynorphins in interictal and postictal psychosis","volume":"151","author":"Bortolato","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib18","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.biopsych.2005.02.030","article-title":"Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats","volume":"57","author":"Bortolato","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00213-002-1179-y","article-title":"Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague\u2013Dawley rats","volume":"164","author":"Broom","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/jpet.102.036525","article-title":"Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice","volume":"303","author":"Broom","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib21","doi-asserted-by":"crossref","first-page":"11614","DOI":"10.1523\/JNEUROSCI.3769-07.2007","article-title":"Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria","volume":"27","author":"Bruchas","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib22","doi-asserted-by":"crossref","first-page":"18081","DOI":"10.1074\/jbc.M513640200","article-title":"Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes","volume":"281","author":"Bruchas","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004850-200307000-00001","article-title":"Noradrenaline in mood and anxiety disorders: basic and clinical studies","volume":"18","author":"Brunello","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib24","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/cne.21086","article-title":"Coexpression of dynorphin and neurokinin B immunoreactivity in the rat hypothalamus: morphologic evidence of interrelated function within the arcuate nucleus","volume":"498","author":"Burke","year":"2006","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/bj3200227","article-title":"Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse delta opioid receptor in Rat-1 fibroblasts: effects of receptor expression levels and comparisons with G-protein activation","volume":"320","author":"Burt","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2826.1996.tb00691.x","article-title":"The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic\u2013pituitary\u2013adrenal axis: studies in vivo and in vitro","volume":"8","author":"Calogero","year":"1996","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1044-7431(03)00040-X","article-title":"Ca(2+)-dependent prodynorphin transcriptional derepression in neuroblastoma cells is exerted through DREAM protein activity in a kinase-independent manner","volume":"22","author":"Campos","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/nn1964","article-title":"Long story short: the serotonin transporter in emotion regulation and social cognition","volume":"10","author":"Canli","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neulet.2008.09.071","article-title":"Lateralization of dynorphin gene expression in the rat striatum","volume":"447","author":"Capper-Loup","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/18044","article-title":"DREAM is a Ca2+-regulated transcriptional repressor","volume":"398","author":"Carrion","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0143-4179(98)90022-1","article-title":"Ifenprodil blocks the excitatory effects of the opioid peptide dynorphin 1-17 on NMDA receptor-mediated currents in the CA3 region of the guinea pig hippocampus","volume":"32","author":"Caudle","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0006-8993(88)91628-9","article-title":"A novel interaction between dynorphin(1-13) and an N-methyl-D-aspartate site","volume":"443","author":"Caudle","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib34","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/brain\/awh524","article-title":"Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here?","volume":"128","author":"Cavalleri","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib35","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1073\/pnas.78.7.4141","article-title":"Novel opiate binding sites selective for benzomorphan drugs","volume":"78","author":"Chang","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib36","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1124\/mol.108.051417","article-title":"Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue","volume":"75","author":"Chartoff","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib37","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1073\/pnas.78.10.6543","article-title":"Specific receptor for the opioid peptide dynorphin: structure\u2013activity relationships","volume":"78","author":"Chavkin","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.6120570","article-title":"Dynorphin is a specific endogenous ligand of the kappa opioid receptor","volume":"215","author":"Chavkin","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib39","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj2950625","article-title":"Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors","volume":"295","author":"Chen","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0092-8674(01)00629-8","article-title":"DREAM is a critical transcriptional repressor for pain modulation","volume":"108","author":"Cheng","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuroscience.2003.07.011","article-title":"Region selective up-regulation of micro-, delta- and kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice","volume":"122","author":"Clarke","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0143-4179(86)90043-0","article-title":"Some projections of dynorphin-immunoreactive neurons in the rat central nervous system","volume":"8","author":"Code","year":"1986","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3565(25)39544-3","article-title":"Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice","volume":"267","author":"Comer","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/74255","article-title":"Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2","volume":"24","author":"Coste","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib45","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/0024-3205(75)90272-6","article-title":"A peptide-like substance from pituitary that acts like morphine.2. Purification and properties","volume":"16","author":"Cox","year":"1975","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib46","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1210\/endo-124-5-2392","article-title":"The posttranslational processing of prodynorphin in the rat anterior pituitary","volume":"124","author":"Day","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib47","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1074\/jbc.273.2.829","article-title":"Prodynorphin processing by proprotein convertase 2. Cleavage at single basic residues and enhanced processing in the presence of carboxypeptidase activity","volume":"273","author":"Day","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib48","series-title":"The dentate gyrus and its role in seizures","first-page":"235","author":"de Lanerolle","year":"1992"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib49","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1528-1157.2003.32701.x","article-title":"A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories","volume":"44","author":"de Lanerolle","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0920-1211(97)00044-2","article-title":"Dynorphin and the kappa 1 ligand [3H]U69,593 binding in the human epileptogenic hippocampus","volume":"28","author":"de Lanerolle","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0306-3623(93)90330-Z","article-title":"Anticonvulsant effects of U-54494A and U-50488H in genetically epilepsy-prone rats and DBA\/2 mice: a possible involvement of glycine\/NMDA receptor complex","volume":"24","author":"De Sarro","year":"1993","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/mcne.1994.1039","article-title":"Distribution of kappa opioid receptor mRNA in adult mouse brain: an in situ hybridization histochemistry study","volume":"5","author":"DePaoli","year":"1994","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib53","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1042\/BST0370308","article-title":"Mutant models for genes associated with schizophrenia","volume":"37","author":"Desbonnet","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib54","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0031-6997(25)06958-3","article-title":"International Union of Pharmacology. XII. Classification of opioid receptors","volume":"48","author":"Dhawan","year":"1996","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib55","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0169-328X(91)90132-H","article-title":"Systemic administration of kainic acid differentially regulates the levels of prodynorphin and proenkephalin mRNA and peptides in the rat hippocampus","volume":"9","author":"Douglass","year":"1991","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib57","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/me.8.3.333","article-title":"Identification of multiple DNA elements regulating basal and protein kinase A-induced transcriptional expression of the rat prodynorphin gene","volume":"8","author":"Douglass","year":"1994","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib58","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1210\/mend-3-12-2070","article-title":"Characterization of the rat prodynorphin gene","volume":"3","author":"Douglass","year":"1989","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib59","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1523\/JNEUROSCI.14-06-03736.1994","article-title":"Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters","volume":"14","author":"Drake","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib60","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0166-2236(92)90019-5","article-title":"Activity-dependent neuronal plasticity following tissue injury and inflammation","volume":"15","author":"Dubner","year":"1992","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0014-5793(94)80630-6","article-title":"Processing of prodynorphin by the prohormone convertase PC1 results in high molecular weight intermediate forms. Cleavage at a single arginine residue","volume":"337","author":"Dupuy","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.12-02-00425.1992","article-title":"Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism","volume":"12","author":"Faden","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/cne.902490302","article-title":"Distribution of dynorphin and enkephalin peptides in the rat brain","volume":"249","author":"Fallon","year":"1986","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0014-4827(02)00102-7","article-title":"Neuregulins: functions, forms, and signaling strategies","volume":"284","author":"Falls","year":"2003","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib65","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.npp.1301149","article-title":"Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice","volume":"32","author":"Fichna","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib67","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/0024-3205(82)90206-5","article-title":"Two \u201cbig\u201d dynorphins from porcine pituitary","volume":"31","author":"Fischli","year":"1982","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib68","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1073\/pnas.79.17.5435","article-title":"Isolation and amino acid sequence analysis of a 4,000-dalton dynorphin from porcine pituitary","volume":"79","author":"Fischli","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0773.1988.tb01863.x","article-title":"Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266","volume":"62","author":"Frey","year":"1988","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib70","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.1996.67031309.x","article-title":"Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells","volume":"67","author":"Fukuda","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib71","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1523\/JNEUROSCI.08-06-01852.1988","article-title":"Seizures induce dramatic and distinctly different changes in enkephalin, dynorphin, and CCK immunoreactivities in mouse hippocampal mossy fibers","volume":"8","author":"Gall","year":"1988","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib72","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1528-1157.2003.18003.x","article-title":"Prodynorphin gene promoter polymorphism and temporal lobe epilepsy","volume":"44","author":"Gambardella","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0304-3959(02)00173-2","article-title":"Dynorphin-independent spinal cannabinoid antinociception","volume":"100","author":"Gardell","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib74","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0006-8993(84)90256-7","article-title":"Dynorphin1-13: interaction with other opiate ligand bindings in vitro","volume":"302","author":"Garzon","year":"1984","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib75","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0306-4522(91)90340-T","article-title":"Role of dynorphin-containing neurons in the presynaptic inhibitory control of the acetylcholine-evoked release of dopamine in the striosomes and the matrix of the cat caudate nucleus","volume":"41","author":"Gauchy","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib76","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1073\/pnas.78.11.7219","article-title":"Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide","volume":"78","author":"Goldstein","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib77","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1073\/pnas.76.12.6666","article-title":"Dynorphin-(1-13), an extraordinarily potent opioid peptide","volume":"76","author":"Goldstein","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib78","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00213-002-1112-4","article-title":"On serotonin and experimental anxiety","volume":"163","author":"Graeff","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib79","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0006-8993(82)90930-1","article-title":"Immunoreactive dynorphin in human brain and pituitary","volume":"233","author":"Gramsch","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib80","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.conb.2005.10.006","article-title":"The basal ganglia: learning new tricks and loving it","volume":"15","author":"Graybiel","year":"2005","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib81","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0891-0618(00)00068-5","article-title":"Kappa opioid receptors are expressed by interneurons in the CA1 area of the rat hippocampus: a correlated light and electron microscopic immunocytochemical study","volume":"19","author":"Halasy","year":"2000","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/syn.20273","article-title":"Dopamine D1 receptors have subcellular distributions conducive to interactions with prodynorphin in the rat nucleus accumbens shell","volume":"60","author":"Hara","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib83","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biopsych.2005.11.002","article-title":"Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology","volume":"60","author":"Harrison","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib84","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0306-4522(94)00529-E","article-title":"Opioid peptide expression in models of chronic temporal lobe epilepsy","volume":"65","author":"Harrison","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib85","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-1781(90)90001-L","article-title":"Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients","volume":"34","author":"Heikkila","year":"1990","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib86","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0166-2236(94)90079-5","article-title":"Corticotropin-releasing factor and neuropeptide Y: role in emotional integration","volume":"17","author":"Heilig","year":"1994","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib87","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/325445a0","article-title":"The GTP-binding protein, Go, regulates neuronal calcium channels","volume":"325","author":"Hescheler","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib88","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0196-9781(83)90080-3","article-title":"Regional interactions of opioid peptides at mu and delta sites in rat brain","volume":"4","author":"Hewlett","year":"1983","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib89","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1098-2396(19991215)34:4<256::AID-SYN2>3.0.CO;2-6","article-title":"Opioid peptide receptor studies. 10. Nor-BNI differentially inhibits kappa receptor agonist-induced G-protein activation in the guinea pig caudate: further evidence of kappa receptor heterogeneity","volume":"34","author":"Heyliger","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib90","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/jn.2001.85.3.1153","article-title":"Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell","volume":"85","author":"Hjelmstad","year":"2001","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib91","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0304-3940(80)90318-3","article-title":"Dynorphin-related immunoreactive peptides in rat brain and pituitary","volume":"18","author":"Hollt","year":"1980","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib92","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0301-0082(93)90020-S","article-title":"Relationship between hippocampal opioid peptides and seizures","volume":"40","author":"Hong","year":"1993","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib93","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(25)38432-6","article-title":"Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse","volume":"266","author":"Horan","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib94","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/306611a0","article-title":"Isolation and structural organization of the human preproenkephalin B gene","volume":"306","author":"Horikawa","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib95","first-page":"223","article-title":"Morphological changes in the dentate gyrus in human temporal lobe epilepsy","volume":"7","author":"Houser","year":"1992","journal-title":"Epilepsy Res Suppl"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib96","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1523\/JNEUROSCI.10-01-00267.1990","article-title":"Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy","volume":"10","author":"Houser","year":"1990","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib97","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejpain.2008.03.010","article-title":"Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse","volume":"13","author":"Huge","year":"2009","journal-title":"Eur J Pain"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib98","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0306-4522(96)00002-4","article-title":"Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain","volume":"72","author":"Hurd","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib99","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.mp.4000319","article-title":"Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects","volume":"2","author":"Hurd","year":"1997","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib100","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/0024-3205(91)90224-Y","article-title":"Enkephalin, dynorphin and substance P in postmortem substantia nigra from normals and schizophrenic patients","volume":"48","author":"Iadarola","year":"1991","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib101","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(86)90738-9","article-title":"Changes in dynorphin, enkephalin and cholecystokinin content of hippocampus and substantia nigra after amygdala kindling","volume":"365","author":"Iadarola","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib102","doi-asserted-by":"crossref","first-page":"E587","DOI":"10.1152\/ajpendo.00612.2005","article-title":"Downstream regulatory element antagonistic modulator regulates islet prodynorphin expression","volume":"291","author":"Jacobson","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib103","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-3565(25)21609-3","article-title":"Opioid receptor selectivity of dynorphin gene products","volume":"228","author":"James","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib104","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0306-4522(99)00249-3","article-title":"Loss of dynorphin-mediated inhibition of voltage-dependent Ca2+ currents in hippocampal granule cells isolated from epilepsy patients is associated with mossy fiber sprouting","volume":"94","author":"Jeub","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib105","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0026-895X(25)09249-1","article-title":"Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma \u00d7 glioma hybrid NG108-15 cells","volume":"42","author":"Jin","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib106","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-8993(97)00103-0","article-title":"Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro","volume":"755","author":"Jolas","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib107","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/298245a0","article-title":"Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin\/dynorphin precursor","volume":"298","author":"Kakidani","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib108","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1523\/JNEUROSCI.06-03-00644.1986","article-title":"Dynorphin- and enkephalin-like immunoreactivity is altered in limbic-basal ganglia regions of rat brain after repeated electroconvulsive shock","volume":"6","author":"Kanamatsu","year":"1986","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib109","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1523\/JNEUROSCI.06-10-03094.1986","article-title":"Kainic acid alters the metabolism of Met5-enkephalin and the level of dynorphin A in the rat hippocampus","volume":"6","author":"Kanamatsu","year":"1986","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1044-7431(03)00214-8","article-title":"Dynorphin A inhibits NMDA receptors through a pH-dependent mechanism","volume":"24","author":"Kanemitsu","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib111","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00213-007-0945-2","article-title":"The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice","volume":"195","author":"Karlsson","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib112","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0149-7634(01)00066-5","article-title":"The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y","volume":"26","author":"Kask","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib113","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1523\/JNEUROSCI.10-10-03421.1990","article-title":"Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin","volume":"10","author":"Kawaguchi","year":"1990","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib114","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0196-9781(82)90063-8","article-title":"Dynorphin immunocytochemistry in the rat central nervous system","volume":"3","author":"Khachaturian","year":"1982","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/74271","article-title":"Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2","volume":"24","author":"Kishimoto","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib116","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.107.127415","article-title":"Anxiolytic-like effects of {kappa}-opioid receptor antagonists in models of unlearned and learned fear in rats","volume":"323","author":"Knoll","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib117","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2008.06.012","article-title":"A role for brain stress systems in addiction","volume":"59","author":"Koob","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib118","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archpsyc.1986.01800080019003","article-title":"A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts","volume":"43","author":"Kosten","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib119","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1476-5381.1981.tb08749.x","article-title":"Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain","volume":"73","author":"Kosterlitz","year":"1981","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib120","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.ALC.0000164361.62346.D6","article-title":"Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice","volume":"29","author":"Kovacs","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib121","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1523\/JNEUROSCI.0390-08.2008","article-title":"Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system","volume":"28","author":"Kreibich","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib122","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.peptides.2004.05.005","article-title":"Modulation of anxiety-related behaviors by mu- and kappa-opioid receptor agonists depends on the social status of mice","volume":"25","author":"Kudryavtseva","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib123","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/sj.npp.1300959","article-title":"Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice","volume":"31","author":"Kuzmin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib124","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(98)00293-6","article-title":"Dynorphin uses a non-opioid mechanism to potentiate N-methyl-D-aspartate currents in single rat periaqueductal gray neurons","volume":"247","author":"Lai","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib125","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/nn1804","article-title":"Dynorphin A activates bradykinin receptors to maintain neuropathic pain","volume":"9","author":"Lai","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib126","first-page":"160","article-title":"Neuropathic pain: the paradox of dynorphin","volume":"1","author":"Lai","year":"2001","journal-title":"Mol Interv"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib127","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-0327(00)00343-8","article-title":"Fear and anxiety: animal models and human cognitive psychophysiology","volume":"61","author":"Lang","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib129","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1365-2982.2008.01161.x","article-title":"Involvement of kappa-opioid receptors in visceral nociception in mice","volume":"20","author":"Larsson","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0169-328X(92)90090-X","article-title":"The effects of excitatory amino acids on proenkephalin and prodynorphin mRNA levels in the hippocampal dentate gyrus of the rat; an in situ hybridization study","volume":"12","author":"Lason","year":"1992","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib131","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0306-4522(92)90320-2","article-title":"The prodynorphin system in the rat hippocampus is differentially influenced by kainic acid and pentetrazole","volume":"51","author":"Lason","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib132","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0022-3565(24)29295-8","article-title":"Mechanisms of induction of persistent nociception by dynorphin","volume":"299","author":"Laughlin","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib133","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0304-3959(97)00046-8","article-title":"Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors","volume":"72","author":"Laughlin","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib134","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0169-328X(89)90072-7","article-title":"Changes of proenkephalin and prodynorphin mRNAs and related peptides in rat brain during the development of deep prepyriform cortex kindling","volume":"6","author":"Lee","year":"1989","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib135","series-title":"Linking emotion to the social brain. The role of the serotonin transporter in human social behaviour","author":"Lesch","year":"2007"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib136","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1042\/bj2950629","article-title":"Molecular cloning and expression of a rat kappa opioid receptor","volume":"295","author":"Li","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib137","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.npep.2005.11.006","article-title":"Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain","volume":"40","author":"Lin","year":"2006","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib138","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/brain\/awl384","article-title":"Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors","volume":"130","author":"Loacker","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib139","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/267495a0","article-title":"Endogenous opioid peptides: multiple agonists and receptors","volume":"267","author":"Lord","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1196\/annals.1410.004","article-title":"Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus","volume":"1148","author":"Lowry","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib141","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0306-4522(03)00397-X","article-title":"Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus","volume":"121","author":"Ma","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib142","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1152\/jn.1999.82.4.1768","article-title":"Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism","volume":"82","author":"Madamba","year":"1999","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib143","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib144","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/mcne.1994.1015","article-title":"Kappa 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA","volume":"5","author":"Mansour","year":"1994","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(95)00928-J","article-title":"The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores","volume":"700","author":"Mansour","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib146","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0166-2236(95)93876-Y","article-title":"Opioid receptors: past, present and future","volume":"18","author":"Mansour","year":"1995","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib147","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1006\/bbrc.1994.2091","article-title":"Isolation of a human kappa opioid receptor cDNA from placenta","volume":"202","author":"Mansson","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib148","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbr.2005.05.005","article-title":"The kappa-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety","volume":"163","author":"Marco","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib149","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1523\/JNEUROSCI.23-31-09981.2003","article-title":"Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons","volume":"23","author":"Margolis","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib150","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1073\/pnas.0511159103","article-title":"Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex","volume":"103","author":"Margolis","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib151","doi-asserted-by":"crossref","first-page":"8908","DOI":"10.1523\/JNEUROSCI.1526-08.2008","article-title":"Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition","volume":"28","author":"Margolis","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib152","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0091-3057(02)01041-9","article-title":"Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats","volume":"74","author":"Marin","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib153","doi-asserted-by":"crossref","first-page":"26360","DOI":"10.1074\/jbc.M412494200","article-title":"Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission","volume":"280","author":"Marinova","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib154","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/BST0370313","article-title":"Is depression associated with dysfunction of the central reward system?","volume":"37","author":"Martin-Soelch","year":"2009","journal-title":"Biochem Soc Trans"},{"issue":"Suppl 3","key":"10.1016\/j.pharmthera.2009.05.006_bib155","doi-asserted-by":"crossref","first-page":"273S","DOI":"10.1111\/j.1365-2125.1979.tb04700.x","article-title":"History and development of mixed opioid agonists, partial agonists and antagonists","volume":"7","author":"Martin","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib156","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib157","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-8993(00)03302-3","article-title":"Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients","volume":"893","author":"Mathieu-Kia","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib158","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0169-328X(02)00562-4","article-title":"Seizure-mediated neuronal activation induces DREAM gene expression in the mouse brain","volume":"109","author":"Matsu-ura","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib159","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0306-4522(87)90015-7","article-title":"Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro","volume":"20","author":"McFadzean","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib160","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1073\/pnas.80.2.589","article-title":"Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity","volume":"80","author":"McGinty","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib161","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0304-3940(86)90252-1","article-title":"Amygdaloid kindling increases enkephalin-like immunoreactivity but decreases dynorphin-A-like immunoreactivity in rat hippocampus","volume":"71","author":"McGinty","year":"1986","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib162","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib163","first-page":"113","article-title":"Cellular and molecular analysis of opioid peptide gene expression","volume":"126","author":"McMurray","year":"1992","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib164","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0006-8993(93)90512-L","article-title":"Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice","volume":"611","author":"Menendez","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib165","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1073\/pnas.90.21.9954","article-title":"Cloning and pharmacological characterization of a rat kappa opioid receptor","volume":"90","author":"Meng","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib166","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1096-9861(19970728)384:2<211::AID-CNE4>3.0.CO;2-4","article-title":"In situ hybridization histochemical localization of prodynorphin messenger RNA in the central nervous system of the rat","volume":"384","author":"Merchenthaler","year":"1997","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib167","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jad.2007.01.032","article-title":"The effects of serotonin manipulations on emotional information processing and mood","volume":"103","author":"Merens","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib168","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0079-6123(08)00912-6","article-title":"The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease","volume":"172","author":"Michelsen","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib169","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0006-8993(84)91424-0","article-title":"Contrasting interactions of the locus coeruleus as compared to the ventral noradrenergic bundle with CNS and pituitary pools of vasopressin, dynorphin and related opioid peptides in the rat","volume":"298","author":"Millan","year":"1984","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib170","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/0006-291X(81)91243-2","article-title":"Beta-neo-endorphin, a new hypothalamic \u201cbig\u201d Leu-enkephalin of porcine origin: its purification and the complete amino acid sequence","volume":"99","author":"Minamino","year":"1981","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib171","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0006-291X(80)80063-5","article-title":"A new opioid octapeptide related to dynorphin from porcine hypothalamus","volume":"95","author":"Minamino","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib172","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3940(90)90859-8","article-title":"Perforant path kindling induces differential alterations in the mRNA levels coding for prodynorphin and proenkephalin in the rat hippocampus","volume":"110","author":"Moneta","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib173","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1523\/JNEUROSCI.14-02-00809.1994","article-title":"Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro","volume":"14","author":"Moore","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib174","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0304-3940(86)90423-4","article-title":"Localization of prodynorphin messenger rna in rat brain by in situ hybridization using a synthetic oligonucleotide probe","volume":"69","author":"Morris","year":"1986","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib175","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0304-3940(87)90471-X","article-title":"Levels of prodynorphin mRNA in rat dentate gyrus are decreased during hippocampal kindling","volume":"80","author":"Morris","year":"1987","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib176","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF02245820","article-title":"Effects of microinjections of mu and kappa receptor agonists into the dorsal periaqueductal gray of rats submitted to the plus maze test","volume":"120","author":"Motta","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib177","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF00432213","article-title":"Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning","volume":"86","author":"Mucha","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib178","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/308278a0","article-title":"Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release","volume":"308","author":"Mulder","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib179","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1176\/ajp.155.2.214","article-title":"Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study","volume":"155","author":"Najavits","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib180","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0896-6273(91)90063-6","article-title":"Molecular pathways of pain: Fos\/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene","volume":"6","author":"Naranjo","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib181","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.npp.1300858","article-title":"Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala","volume":"31","author":"Narita","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib182","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","article-title":"The mesolimbic dopamine reward circuit in depression","volume":"59","author":"Nestler","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib183","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1073\/pnas.89.10.4270","article-title":"Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine","volume":"89","author":"Nguyen","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib184","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0306-4522(89)90049-3","article-title":"Presynaptic auto- and allelo-receptor regulation of hypothalamic opioid peptide release","volume":"31","author":"Nikolarakis","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib185","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1096\/fj.05-3743fje","article-title":"Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brain","volume":"19","author":"Nikoshkov","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib186","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(00)00589-6","article-title":"Blockade of mu- and activation of kappa-opioid receptors in the dorsal periaqueductal gray matter produce defensive behavior in rats tested in the elevated plus-maze","volume":"404","author":"Nobre","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib187","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1073\/pnas.84.15.5487","article-title":"Mu and delta receptors belong to a family of receptors that are coupled to potassium channels","volume":"84","author":"North","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib188","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.psyneuen.2008.01.006","article-title":"Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic\u2013pituitary\u2013adrenal axis in monkeys","volume":"33","author":"Pascoe","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib189","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0361-9230(01)00525-1","article-title":"Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders","volume":"55","author":"Peckys","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib190","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib191","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/1098-2396(20010301)39:3<249::AID-SYN1006>3.0.CO;2-5","article-title":"Parallel increases in the synaptic and surface areas of mossy fiber terminals following seizure induction","volume":"39","author":"Pierce","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib192","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1098-1063(1999)9:3<255::AID-HIPO6>3.0.CO;2-S","article-title":"Morphometry of a peptidergic transmitter system: dynorphin B-like immunoreactivity in the rat hippocampal mossy fiber pathway before and after seizures","volume":"9","author":"Pierce","year":"1999","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib193","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0306-4522(92)90123-J","article-title":"A highly selective kappa-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro","volume":"47","author":"Pinnock","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib194","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0006-8993(10)80029-0","article-title":"Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphe nucleus in vitro","volume":"583","author":"Pinnock","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0361-9230(00)00328-2","article-title":"Basal levels and alcohol-induced changes in nociceptin\/orphanin FQ, dynorphin, and enkephalin levels in C57BL\/6J mice","volume":"53","author":"Ploj","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib196","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/BF02245945","article-title":"Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze","volume":"118","author":"Privette","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib197","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0304-3940(95)11303-E","article-title":"Kappa opioid receptor agonists suppress absence seizures in WAG\/Rij rats","volume":"186","author":"Przewlocka","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib198","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0014-2999(81)90125-4","article-title":"Dynorphins: similar relative potencies on mu, delta- and kappa-opiate receptors","volume":"76","author":"Quirion","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib199","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0006-8993(02)02259-X","article-title":"Kappa opioid receptor is expressed by somatostatin- and neuropeptide Y-containing interneurons in the rat hippocampus","volume":"931","author":"Racz","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib200","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0026-895X(25)09932-8","article-title":"Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors","volume":"45","author":"Raynor","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib201","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000112867","article-title":"Antidepressant-like effects of the novel kappa opioid antagonist MCL-144B in the forced-swim test","volume":"81","author":"Reindl","year":"2008","journal-title":"Pharmacology"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2009.05.006_bib202","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib203","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/cne.21880","article-title":"Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleus","volume":"512","author":"Reyes","year":"2009","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib204","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/cne.21683","article-title":"Dynorphin and stress-related peptides in rat locus coeruleus: contribution of amygdalar efferents","volume":"508","author":"Reyes","year":"2008","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib205","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.neuroscience.2006.12.056","article-title":"Dynorphin-containing axons directly innervate noradrenergic neurons in the rat nucleus locus coeruleus","volume":"145","author":"Reyes","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib206","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/10826088309027352","article-title":"A longitudinal study of life stress and social support among drug abusers","volume":"18","author":"Rhoads","year":"1983","journal-title":"Int J Addict"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib207","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0306-4522(92)90054-6","article-title":"Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine","volume":"46","author":"Robertson","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib208","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-3565(25)23800-9","article-title":"Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity","volume":"271","author":"Robertson","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib209","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hipo.10078","article-title":"Opioid peptide release in the rat hippocampus after kainic acid-induced status epilepticus","volume":"13","author":"Rocha","year":"2003","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib210","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1471-4159.1997.68020616.x","article-title":"Amygdala kindling modifies extracellular opioid peptide content in rat hippocampus measured by microdialysis","volume":"68","author":"Rocha","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib211","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1460-9568.1995.tb00705.x","article-title":"Early changes in prodynorphin mRNA and ir-dynorphin A levels after kindled seizures in the rat","volume":"7","author":"Romualdi","year":"1995","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib212","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0169-328X(92)90115-R","article-title":"Alterations in mRNA of enkephalin, dynorphin and thyrotropin releasing hormone during amygdala kindling: an in situ hybridization study","volume":"15","author":"Rosen","year":"1992","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib213","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1523\/JNEUROSCI.17-17-06565.1997","article-title":"Kappa-opioid receptor activation modulates Ca2+ currents and secretion in isolated neuroendocrine nerve terminals","volume":"17","author":"Rusin","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib214","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejphar.2007.10.038","article-title":"Bi-phasic intensity-dependent opioid-mediated neural amplitude changes in the chinchilla cochlea: partial blockade by an N-Methyl-D-Aspartate (NMDA)-receptor antagonist","volume":"580","author":"Sahley","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.npep.2004.05.006","article-title":"Interactions between NPY and CRF in the amygdala to regulate emotionality","volume":"38","author":"Sajdyk","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib216","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1523\/JNEUROSCI.15-10-06939.1995","article-title":"A comparison of the role of dynorphin in the hippocampal mossy fiber pathway in guinea pig and rat","volume":"15","author":"Salin","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib217","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pain.2008.01.023","article-title":"Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation","volume":"138","author":"Schepers","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib218","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1098-1063(1998)8:3<274::AID-HIPO9>3.0.CO;2-J","article-title":"Glutamate-stimulated neuropeptide Y mRNA expression in the rat dentate gyrus: a prominent role of metabotropic glutamate receptors","volume":"8","author":"Schwarzer","year":"1998","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib219","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.1998.tb10727.x","article-title":"Precursor convertases: an evolutionary ancient, cell-specific, combinatorial mechanism yielding diverse bioactive peptides and proteins","volume":"839","author":"Seidah","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib220","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/endo-115-2-662","article-title":"Proenkephalin B (prodynorphin)-derived opioid peptides: evidence for a differential processing in lobes of the pituitary","volume":"115","author":"Seizinger","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib221","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1054\/npep.1999.0023","article-title":"Isolation and characterization of the mouse homolog of the preprodynorphin (Pdyn) gene","volume":"33","author":"Sharifi","year":"1999","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib222","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0169-328X(00)00264-3","article-title":"Generation of dynorphin knockout mice","volume":"86","author":"Sharifi","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib223","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1073\/pnas.74.8.3365","article-title":"Opiate-dependent modulation of adenylate cyclase","volume":"74","author":"Sharma","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib224","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-6147(03)00027-0","article-title":"Salvinorin A: the \u201cmagic mint\u201d hallucinogen finds a molecular target in the kappa opioid receptor","volume":"24","author":"Sheffler","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib225","first-page":"563","article-title":"Differential effects of mu and kappa opioid systems on motivational processes","volume":"75","author":"Shippenberg","year":"1986","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib226","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","article-title":"Dynorphin and the pathophysiology of drug addiction","volume":"116","author":"Shippenberg","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib227","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","article-title":"Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects","volume":"90","author":"Shirayama","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib228","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0165-6147(94)90091-4","article-title":"Non-opioid effects of dynorphins: possible role of the NMDA receptor","volume":"15","author":"Shukla","year":"1994","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib229","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0896-6273(95)90273-2","article-title":"L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells","volume":"14","author":"Simmons","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-8993(79)90085-4","article-title":"Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase","volume":"178","author":"Simon","year":"1979","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib231","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0301-0082(96)00045-7","article-title":"Dynorphin and epilepsy","volume":"50","author":"Simonato","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib232","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1073\/pnas.92.15.7006","article-title":"kappa-opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system","volume":"92","author":"Simonin","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib233","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/emboj\/17.4.886","article-title":"Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal","volume":"17","author":"Simonin","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib234","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0006-8993(98)01201-3","article-title":"Quantitative autoradiography of mu-,delta- and kappa1 opioid receptors in kappa-opioid receptor knockout mice","volume":"818","author":"Slowe","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib235","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0896-6273(00)80491-2","article-title":"Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development","volume":"20","author":"Smith","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib236","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awl008","article-title":"Kappa opioid control of seizures produced by a virus in an animal model","volume":"129","author":"Solbrig","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib237","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.nbd.2006.05.014","article-title":"Viral risk factor for seizures: pathobiology of dynorphin in herpes simplex viral (HSV-1) seizures in an animal model","volume":"23","author":"Solbrig","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib238","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib239","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1749-6632.1996.tb15110.x","article-title":"CRH overproduction in transgenic mice: behavioral and immune system modulation","volume":"780","author":"Stenzel-Poore","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib240","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.10108","article-title":"A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy","volume":"51","author":"Stogmann","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib241","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/cne.903530410","article-title":"Opioid precursor gene expression in the human hypothalamus","volume":"353","author":"Sukhov","year":"1995","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib242","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1113\/jphysiol.1990.sp018349","article-title":"Inhibition of calcium currents by noradrenaline, somatostatin and opioids in guinea-pig submucosal neurones","volume":"431","author":"Surprenant","year":"1990","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib243","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0006-8993(76)90207-9","article-title":"The locus coeruleus: a cytoarchitectonic, Golgi and immunohistochemical study in the albino rat","volume":"110","author":"Swanson","year":"1976","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib244","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1254\/jjp.53.487","article-title":"Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia","volume":"53","author":"Takahashi","year":"1990","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib245","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0014-2999(00)00569-0","article-title":"Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies","volume":"405","author":"Tanaka","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib246","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0006-8993(02)03180-3","article-title":"Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism","volume":"952","author":"Tan-No","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib247","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pain.2004.11.004","article-title":"Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation","volume":"113","author":"Tan-No","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib248","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/jpet.102.037861","article-title":"Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system","volume":"303","author":"Tao","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib249","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0006-8993(98)00706-9","article-title":"Human prodynorphin gene generates several tissue-specific transcripts","volume":"804","author":"Telkov","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib250","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1523\/JNEUROSCI.20-12-04379.2000","article-title":"Opioid modulation of recurrent excitation in the hippocampal dentate gyrus","volume":"20","author":"Terman","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib251","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/0024-3205(75)90271-4","article-title":"A peptide-like substance from pituitary that acts like morphine.I","volume":"16","author":"Teschemacher","year":"1975","journal-title":"Isolation. Life Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib252","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/520","article-title":"Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1","volume":"19","author":"Timpl","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib253","first-page":"440","article-title":"Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications","volume":"178","author":"Toll","year":"1998","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib254","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0024-3205(89)90470-0","article-title":"Selective kappa antagonist properties of nor-binaltorphimine in the rat MES seizure model","volume":"44","author":"Tortella","year":"1989","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib255","doi-asserted-by":"crossref","first-page":"PL1","DOI":"10.1016\/0024-3205(90)90501-H","article-title":"PD117302, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in rats","volume":"46","author":"Tortella","year":"1990","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib256","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-3565(25)24991-6","article-title":"U50,488, a highly selective kappa opioid: anticonvulsant profile in rats","volume":"237","author":"Tortella","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib257","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.1824728","article-title":"Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801","volume":"251","author":"Trujillo","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib258","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-2999(96)00219-1","article-title":"Involvement of the opioid system in the anxiolytic effect of diazepam in mice","volume":"307","author":"Tsuda","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib259","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0306-4522(92)90412-U","article-title":"Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input","volume":"48","author":"Valentino","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cne.903510111","article-title":"Dynorphin-immunoreactive neurons in the rat nucleus accumbens: ultrastructure and synaptic input from terminals containing substance P and\/or dynorphin","volume":"351","author":"Van Bockstaele","year":"1995","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib261","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0304-3959(96)03225-3","article-title":"Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone","volume":"68","author":"Vanderah","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib262","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000063571","article-title":"Allelic variation in the human prodynorphin gene promoter and schizophrenia","volume":"46","author":"Ventriglia","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib263","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(82)90477-0","article-title":"Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway","volume":"85","author":"Vincent","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib264","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0304-3940(82)90249-X","article-title":"Dynorphin-immunoreactive neurons in the central nervous system of the rat","volume":"33","author":"Vincent","year":"1982","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib265","first-page":"615","article-title":"Hypertension and anxiety. A trial with epinephrine and norepinephrine infusion","volume":"41","author":"Vlachakis","year":"1974","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib266","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0022-3565(25)11010-0","article-title":"U-54494A: a unique anticonvulsant related to kappa opioid agonists","volume":"243","author":"VonVoigtlander","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib267","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(25)33422-1","article-title":"U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist","volume":"224","author":"VonVoigtlander","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib268","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neulet.2006.12.041","article-title":"Dynorphin displaces binding at the glycine site of the NMDA receptor in the rat striatum","volume":"415","author":"Voorn","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib269","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1523\/JNEUROSCI.12-01-00132.1992","article-title":"Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus","volume":"12","author":"Wagner","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib270","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/363451a0","article-title":"Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus","volume":"363","author":"Wagner","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib271","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.8380941","article-title":"Modulation of anxiety and neuropeptide Y\u2013Y1 receptors by antisense oligodeoxynucleotides","volume":"259","author":"Wahlestedt","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib272","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1126\/science.6128791","article-title":"Nonopiate effects of dynorphin and des-Tyr-dynorphin","volume":"218","author":"Walker","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib273","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(95)00544-Z","article-title":"Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain","volume":"688","author":"Wan","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib274","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1523\/JNEUROSCI.21-05-01779.2001","article-title":"Pronociceptive actions of dynorphin maintain chronic neuropathic pain","volume":"21","author":"Wang","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(92)90310-6","article-title":"Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels","volume":"582","author":"Watkins","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib276","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1073\/pnas.80.3.891","article-title":"Pro-dynorphin peptides are found in the same neurons throughout rat brain: immunocytochemical study","volume":"80","author":"Watson","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib277","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1073\/pnas.80.4.1125","article-title":"Immunohistochemical distribution of dynorphin B in rat brain: relation to dynorphin A and alpha-neo-endorphin systems","volume":"80","author":"Weber","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib278","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/362423a0","article-title":"The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation","volume":"362","author":"Weisskopf","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib279","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0022-3565(25)21016-3","article-title":"Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs","volume":"246","author":"Werling","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib280","first-page":"145","article-title":"Psychopharmacology of anxiety disorders: on the role of serotonin in the treatment of anxiety states and phobic disorders","volume":"23","author":"Westenberg","year":"1987","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib281","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/cne.901940308","article-title":"Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular inject of horseradish peroxidase","volume":"194","author":"Wilson","year":"1980","journal-title":"J Comp Neurol"},{"issue":"Suppl","key":"10.1016\/j.pharmthera.2009.05.006_bib282","first-page":"34","article-title":"Serotonin: a possible mediator of behavioral suppression induced by anxiety","volume":"31","author":"Wise","year":"1970","journal-title":"Dis Nerv Syst"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib283","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/npp.2008.142","article-title":"Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone","volume":"34","author":"Wittmann","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib284","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/pr060016+","article-title":"Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity","volume":"5","author":"Woods","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib285","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0006-8993(89)91230-4","article-title":"Deep prepyriform cortex kindling differentially alters the levels of prodynorphin mRNA in rat hippocampus and striatum","volume":"495","author":"Xie","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib286","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0169-328X(89)90023-5","article-title":"Single or repeated electroconvulsive shocks alter the levels of prodynorphin and proenkephalin mRNAs in rat brain","volume":"6","author":"Xie","year":"1989","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib287","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1096\/fj.06-6174fje","article-title":"Prodynorphin storage and processing in axon terminals and dendrites","volume":"20","author":"Yakovleva","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib288","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1073\/pnas.90.14.6736","article-title":"Cloning and functional comparison of kappa and delta opioid receptors from mouse brain","volume":"90","author":"Yasuda","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib289","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1021\/jm00163a034","article-title":"Synthesis and structure\u2013activity relationships of dynorphin A-(1-8) amide analogues","volume":"33","author":"Yoshino","year":"1990","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib290","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0306-4522(94)90540-1","article-title":"The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis-II. Effects of dopamine D1 and D2 receptor agonists","volume":"63","author":"You","year":"1994","journal-title":"Neuroscience"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2009.05.006_bib291","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0024-3205(83)90499-X","article-title":"[3H] dynorphin binding to guinea pig and rat brain","volume":"33","author":"Young","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib292","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0014-2999(86)90256-6","article-title":"[3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain","volume":"121","author":"Young","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib293","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0006-8993(84)90460-8","article-title":"Distribution of immunoreactive dynorphin A1-8 in discrete nuclei of the rat brain: comparison with dynorphin A","volume":"307","author":"Zamir","year":"1984","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib294","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1523\/JNEUROSCI.04-05-01248.1984","article-title":"Distribution of immunoreactive beta-neo-endorphin in discrete areas of the rat brain and pituitary gland: comparison with alpha-neo-endorphin","volume":"4","author":"Zamir","year":"1984","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib295","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1523\/JNEUROSCI.04-05-01240.1984","article-title":"The distribution of immunoreactive alpha-neo-endorphin in the central nervous system of the rat","volume":"4","author":"Zamir","year":"1984","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib296","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-8993(84)91346-5","article-title":"Distribution of immunoreactive dynorphin B in discrete areas of the rat brain and spinal cord","volume":"300","author":"Zamir","year":"1984","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib297","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1152\/jn.1997.78.2.582","article-title":"Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations","volume":"78","author":"Zhang","year":"1997","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib298","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2007.05.045","article-title":"Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies","volume":"570","author":"Zhang","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib299","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)37567-6","article-title":"Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family","volume":"286","author":"Zhang","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib300","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0143-4179(85)90077-0","article-title":"Lower CSF level of dynorphin(1\u20138) immunoreactivity in schizophrenic patients","volume":"5","author":"Zhang","year":"1985","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib301","doi-asserted-by":"crossref","first-page":"PL201","DOI":"10.1016\/0024-3205(94)00507-O","article-title":"Cloning of a human kappa opioid receptor from the brain","volume":"56","author":"Zhu","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2009.05.006_bib302","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)36877-6","article-title":"Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands","volume":"282","author":"Zhu","year":"1997","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725809001107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725809001107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T19:46:00Z","timestamp":1739130360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725809001107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":302,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0163725809001107"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2009.05.006","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}